https://www.avient.com/resources/safety-data-sheets?page=6101
SF263118-05 EXPB90UBF PLAST CAP WHT
SF263118-05 EXPB90UBF PLAST CAP WHT
SF263118-06 EXPB5DUBF KEE CAP WHT
https://www.avient.com/products/fiber-line-engineered-fiber-solutions/high-performance-synthetic-fibers/technora-fiber
500
https://www.avient.com/products/polymer-colorants/colorant-dispersions/stan-tone-wdn-water-based-dispersions
Custom blending available on minimum batch sizes of 500 gallons
https://www.avient.com/sites/default/files/2023-12/Polish Tax Strategy 2022 %5BPL%5D.pdf
Informacje odnośnie do realizacji przez podatnika obowiązków
podatkowych na terytorium Rzeczypospolitej Polskiej, wraz z
informacją o liczbie przekazanych Szefowi Krajowej Informacji
Skarbowej informacji o schematach podatkowych, o których mowa
w art. 86a § 1 pkt 10 Ordynacji podatkowej, z podziałem na podatki
których dotyczą (art. 27c ust. 2 pkt 2 CIT Akt)
Spółka w roku 2022 realizowała następujące obowiązki podatkowe:
• Ceny transferowe
• Podatek od osób prawnych (CIT)
• Podatek od osób fizycznych (PIT)
• Podatek od towarów i usług (VAT)
• Podatek od nieruchomości
• Podatek od osób fizycznych (PIT)
• Podatek u źródła (WHT)
• Ceny transferowe
Ceny transferowe
Spółka dba oraz przestrzega wywiązywania się z obowiązku realizowania przepisów o cenach
transferowych.
https://www.avient.com/sites/default/files/2024-11/Polish Tax Strategy 2023 %5BPL%5D.pdf
Informacje odnośnie do realizacji przez podatnika obowiązków
podatkowych na terytorium Rzeczypospolitej Polskiej, wraz z
informacją o liczbie przekazanych Szefowi Krajowej Informacji
Skarbowej informacji o schematach podatkowych, o których mowa
w art. 86a § 1 pkt 10 Ordynacji podatkowej, z podziałem na podatki
których dotyczą (art. 27c ust. 2 pkt 2 CIT Akt)
Spółka w roku 2023 realizowała następujące obowiązki podatkowe:
• Ceny transferowe
• Podatek od osób prawnych (CIT)
• Podatek od osób fizycznych (PIT)
• Podatek od towarów i usług (VAT)
• Podatek od nieruchomości
• Podatek u źródła (WHT)
• Ceny transferowe
Ceny transferowe
Spółka dba oraz przestrzega wywiązywania się z obowiązku realizowania przepisów o cenach
transferowych.
https://www.avient.com/sites/default/files/2023-11/AVNT November IR Presentation.pdf
&
Canada
EMEA
Asia
Latin America
64%
36%
Specialty
Engineered
Materials
Color
Additives
and Inks
40%
37%
18%
5%
6%
8%
24%
20%
10%
15%
9% 4% 4%
Defense
Healthcare
Packaging
Consumer
Building &
Construction
Industrial
Transportation
Energy Telecom
Geography
Segment
Industry
4
CRE AT ING A WORL D-CL AS S
S US TAINABL E ORGANIZ AT ION
1. 6% annualized long term sales
growth leveraging sustainable
solutions, composites, healthcare
and emerging regions
2.
PRIOR YEAR
$790
$710
2022 2023
$107
$112
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.47
2022 PF 2023
Adjusted EPS
(in millions)
- 10% + 5% + 12%
Sales Adjusted EBITDA Adjusted EPS
16
$112
$500
Q4 FY
$0.47
$2.30
Q4 FY
Q4 AND FULL YEAR 2023 GUIDANCE
$710
$3,130
Q4 FY
Sales Adjusted EBITDA Adjusted EPS
17
(in millions) (in millions)
Guidance: Free Cash Flow
$180 $180
Prior Guidance Guidance
FREE CASH FLOW & INCREASED DIVIDEND
13th Consecutive Dividend Increase
0.16
0.26
0.42
0.58
0.79
0.85
0.99
1.03
2011 2013 2015 2017 2019 2021 2023 2024
18
S U S T A I N A B I L I T Y D AY
R E C A P
SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS
60%+
Key Growth
Drivers
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
(GDP Growth)
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other (GDP growth) 0–2%
Avient 6%
20
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
8-12%
Long Term
Growth
50
90
2022 2030
Medical Plastics
Market Size
(in $Billions)
2020 2030
Recycled
Plastics
Virgin
Plastics
Growing Demand
for Recycled
Content
Avient Sustainable
Solutions
18
46
2023 2032
Global Offshore Annual
Wind Installations
(in Gigawatts)
Sources: McKinsey, Bloomberg, Grand View Research
SUSTAINABILITY TRENDS DRIVE
LONG-TERM GROWTH
21
• Transformative acquisitions
combined with divestitures of
more cyclical businesses have
improved margins over 400 bps
since 2018
• 20% long-term margin goal to
be driven by key growth drivers,
with sustainable solutions
playing a meaningful role
5.4%
11.5%
16.0%
2006 2018 2023E Recovery Growth
Drivers
Strategic
Objective
20%+
+1%+
+3%+
ADJUSTED EBITDA MARGIN EXPANSION
22
• 6% annualized long-term sales growth leveraging
sustainable solutions, composites, healthcare, and
emerging regions
• Expand EBITDA margins to 20%
• Deliver annual EBITDA and EPS growth of
10% and 15%
• Maintain asset-light, 80% free cash flow conversion
profile and be valued as a specialty formulator
• Continue fostering our Great Place to Work® culture
CRE AT ING A WORL D-CL AS S
S US TAINABL E ORGANIZ AT ION
23
PEER COMPARISONS
AVIENT IS ASSET LIGHT
Capex / Revenue
2023E (%)
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
Source: Peer data per Bloomberg as of October 27, 2023
Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M.
26
3.5
1.8
2.7 3.0
3.4 3.7
2.8
3.7
4.6 5.0
6.9 7.0
8.6
11.1
A
vi
en
t
K
W
R
FU
L
P
P
G
A
V
Y
R
P
M
FM
C
H
U
N
C
E
E
C
L
A
S
H
H
X
L
E
M
N
S
C
L
FREE CASH FLOW CONVERSION
Source: Peer data per Bloomberg as of October 27, 2023
Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.
https://www.avient.com/sites/default/files/2023-11/AVNT Q3 2023 Earnings Presentation - Website.pdf
PRIOR YEAR
$790
$710
2022 2023
$107
$112
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.47
2022 PF 2023
Adjusted EPS
(in millions)
- 10% + 5% + 12%
Sales Adjusted EBITDA Adjusted EPS
12
$112
$500
Q4 FY
$0.47
$2.30
Q4 FY
Q4 AND FULL YEAR 2023 GUIDANCE
$710
$3,130
Q4 FY
Sales Adjusted EBITDA Adjusted EPS
13
(in millions) (in millions)
Guidance: Free Cash Flow
$180 $180
Prior Guidance Guidance
FREE CASH FLOW & INCREASED DIVIDEND
13th Consecutive Dividend Increase
0.16
0.26
0.42
0.58
0.79
0.85
0.99
1.03
2011 2013 2015 2017 2019 2021 2023 2024
14
S U S T A I N A B I L I T Y D AY
R E C A P
SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS
60%+
Key Growth
Drivers
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
(GDP Growth)
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other (GDP growth) 0–2%
Avient 6%
17
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
8-12%
Long Term
Growth
50
90
2022 2030
Medical Plastics
Market Size
(in $Billions)
2020 2030
Recycled
Plastics
Virgin
Plastics
Growing Demand
for Recycled
Content
Avient Sustainable
Solutions
18
46
2023 2032
Global Offshore Annual
Wind Installations
(in Gigawatts)
Sources: McKinsey, Bloomberg, Grand View Research
SUSTAINABILITY TRENDS DRIVE
LONG-TERM GROWTH
18
• Transformative acquisitions
combined with divestitures of
more cyclical businesses have
improved margins over 400 bps
since 2018
• 20% long-term margin goal to
be driven by key growth drivers,
with sustainable solutions
playing a meaningful role
5.4%
11.5%
16.0%
2006 2018 2023E Recovery Growth
Drivers
Strategic
Objective
20%+
+1%+
+3%+
ADJUSTED EBITDA MARGIN EXPANSION
19
• 6% annualized long-term sales growth leveraging
sustainable solutions, composites, healthcare, and
emerging regions
• Expand EBITDA margins to 20%
• Deliver annual EBITDA and EPS growth of
10% and 15%
• Maintain asset-light, 80% free cash flow conversion
profile and be valued as a specialty formulator
• Continue fostering our Great Place to Work® culture
CRE AT ING A WORL D-CL AS S
S US TAINABL E ORGANIZ AT ION
20
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/idea/carbon-fiber-composites
With a typical tensile strength of 400 – 500 ksi and average density of 1.55 g/cc, CFRP composites can be up to 10 times stronger and 5 times lighter than steel.
https://www.avient.com/idea/tier-1-auto-supplier-saves-supply-chain-expansion
The shape processed more efficiently, delivering a cycle-time reduction and, more significantly, reducing wear on the material handling equipment that carried the pellets 500 feet from silo to press.
https://www.avient.com/sites/default/files/2022-03/Asia SEM Healthcare Product Selection Guide %281%29.pdf
PP OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS
Dynaflex™ G2706 28A
USP Class VI, ISO 10993,
Food contact
EtO
Soft translucent grade,
grippy feel
Dynaflex™ G2711 43A
USP Class VI, ISO 10993,
Food contact
EtO
Highly colorable solution,
grippy feel, low compression set
Versaflex™
CL2242 & CL2250
42A/ 50A
USP Class VI, ISO 10993,
US Food contact
EtO
Clear boilable grades;
ABS, PC bondable
Versaflex™ G2705 N 60A
USP Class VI, ISO 10993,
Food contact
EtO/Steam
High resilience,
low compression set
Versaflex™ HC3810 20A-90A USP Class VI, ISO 10993 EtO General purpose, unfilled
ABS, PC OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS
Versaflex™ OM1040 40A USP Class VI, ISO 10993 EtO Translucent
Versaflex™ OM3060 60A USP Class VI, ISO 10993 EtO Clear
VERSAFLEX™ CL AND DYNAFLEX™ TPEs
OVERMOLDING FOR
ERGONOMICS
• Adds good tactile surface with soft-touch feel
• Available in a variety of color effects and
textures
• Improves grip, cushion, and comfort
• Enhances functional performance like sealing
properties, vibration damping, oxygen
barrier, and scratch and abrasion resistance
• Reduces assembly costs, good processability
• Offers excellent adhesion to a wide range of
substrates
Applications:
• Glucometers
• Medical tools overmolds
• Injector pens
• Analysis devices
VERSALLOY™ HC & VERSAFLEX™ HC TPEs
SEALING & RESEALING
• Rubbery feel and soft touch
• No coring, good puncture, and
resealability in static stoppers
• Meets low coefficient of friction
requirements in dynamic seals
• Low extractables
• Suitable to overmold onto polyolefins
Applications:
• Sealing and resealing septum
• Seals and sanitary gaskets
• Syringe plungers and tips
MATERIAL DESCRIPTION HARDNESS REGULATORY STERILIZATION CHARACTERISTICS
Versalloy™
HC 9210-45N
45A USP Class VI EtO
Good processability,
smooth surface aesthetics
Versalloy™
HC 9210-55N
55A USP Class VI EtO
Good processability,
smooth surface aesthetics
Versalloy™
HC 9210-70N
70A USP Class VI EtO
Good processability,
smooth surface aesthetics
Versalloy™
HC 9220-43N
43A
USP Class VI,
ISO 10993-4/5
EtO
Extrusion grade,
high temperature resistance
Versaflex™
HC 2110-35N
34A
FDA, USP Class VI,
ISO 10993
Autoclave EtO
radiation
Resealing, elevated comp set
Versaflex™
HC 2110-57B
57A
FDA, USP Class VI,
ISO 10993
Autoclave EtO
radiation
Low stiction
VERSAFLEX™ CL AND DYNAFLEX™ TPEs
HIGH CLARITY
GRADES WITHOUT
PLASTICIZERS
• Water clear grades formulated without
phthalate plasticizers
• Meets medical regulatory USP Class VI and
ISO 10993-4,5
• Food contact and FDA compliant
• Autoclave and radiation stable
• Low extractable
• High clarity (Haze 50 4.1, 100 4.5, 100 4, 70 6, 70
Tensile Modulus (MPa) 2200 2700 2600 2350 1820 1820
Flexural Strength (MPa) 80 90 104 86 68 68
Flexural Modulus (MPa) 2500 2700 2500 2300 1980 1590
HDT: 0.45, 1.8 (MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70
UL-94 Rating @ 3.0 mm 5VA V-0 5VA V-0 HB V-0
UL-94 Rating @ 1.5 mm V-0 V-0 5VB V-0 HB V-0
UL-94 Rating @ 0.75 mm V-1 V-2 V-0 None None V-2
COMPETITIVE MATERIAL COMPARISON
ENGINEERED POLYMER FORMULATIONS
FOR HEALTHCARE
TRILLIANT™ HC THERMOPLASTICS
The family of Trilliant™ HC high-performance thermoplastics is formulated to meet the growing challenges
of medical devices and equipment.